Canada markets open in 7 hours 41 minutes

Defence Therapeutics Inc. (DTC.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.6000+0.0600 (+11.11%)
At close: 01:37PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 27.32M
Enterprise Value 29.01M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)89.80
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.45
52-Week Change 3-79.31%
S&P500 52-Week Change 333.56%
52 Week High 33.0000
52 Week Low 30.0000
50-Day Moving Average 30.6082
200-Day Moving Average 31.2576

Share Statistics

Avg Vol (3 month) 329.71k
Avg Vol (10 day) 323.12k
Shares Outstanding 545.54M
Implied Shares Outstanding 645.54M
Float 843.03M
% Held by Insiders 14.74%
% Held by Institutions 10.00%
Shares Short (Sept 13, 2024) 4920
Short Ratio (Sept 13, 2024) 40.02
Short % of Float (Sept 13, 2024) 4N/A
Short % of Shares Outstanding (Sept 13, 2024) 40.00%
Shares Short (prior month Jul 31, 2024) 4402

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2024
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-397.30%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -12.68M
Net Income Avi to Common (ttm)-13.19M
Diluted EPS (ttm)-0.3000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)56.55k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.75M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.05
Book Value Per Share (mrq)-0.08

Cash Flow Statement

Operating Cash Flow (ttm)-4.29M
Levered Free Cash Flow (ttm)88.21k